featured
Carboplatin Plus Paclitaxel Dosing in Advanced Ovarian Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Carboplatin Plus Paclitaxel Once a Week Versus Every 3 Weeks in Patients With Advanced Ovarian Cancer (MITO-7): A Randomised, Multicentre, Open-Label, Phase 3 Trial
Lancet Oncol 2014 Apr 01;15(4)396-405, S Pignata, G Scambia, D Katsaros, C Gallo, E Pujade-Lauraine, S De Placido, A Bologna, B Weber, F Raspagliesi, PB Panici, G Cormio, R Sorio, MG Cavazzini, G Ferrandina, E Breda, V Murgia, C Sacco, S Cinieri, V Salutari, C Ricci, C Pisano, S Greggi, R Lauria, D Lorusso, C Marchetti, L Selvaggi, S Signoriello, MC Piccirillo, M Di Maio, F PerroneFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.